DiceX
Posted - 1 day ago
My 3 holds .. not selling . $CMRX $NOTE & $RIVN
Funxs
Posted - 2 days ago
$CMRX love how quiet this thread is with $1.60 cash no debt and a ph3 decision before yr end
Ja094387
Posted - 3 days ago
$CMRX where the news at
ARDX_Bull
Posted - 3 days ago
@pablo4 Yeah stop the Australia filings immediately is definitely the right decision. But from the sudden NDA filing allowance news on Monday 12/10 it sure sounded like $CMRX management was shocked too, happily thou. Lately I was reading the previous PH2 results disclosures and many Company presentations… just wondering what data they have put into the NDA AA filing to score a TD instead of any past communications between FDA and Sherman of ”he said...I thought …then nothing to file …but Ph3 enrolling is a must!” I am not gun shy or second guess but reading what you recommended VSTM today and thinking what had happened to us in past 4 yrs...Just kind of thinking man we give too much power to those FDA officials to flip and flop in their freedom of policy interpretations ! Biden did his White House Cancer event 2 yrs ago? and now we’re finally allowed to file when he’s less than 30- day left! And I just hope those guys in charge not changing mind again on us when Aug comes.
ARDX_Bull
Posted - 3 days ago
@pablo4 And have to pray the $cmrx management team prepared a perfect package for the NDA filing, not getting any correction or demands for additional data or AdCom requirement then we could get end of Aug PDUFA assigned the earliest. Fair to say There are potential issues during this NDA FILING Review of ACCEPTANCE or REJECT in AS IS. Do I understand the timeline correctly ? https://www.businesswire.com/news/home/20241230294719/en/Verastem-Oncology-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Avutometinib-in-Combination-with-Defactinib-for-the-Treatment-of-Recurrent-KRAS-Mutant-Low-Grade-Serous-Ovarian-Cancer
pablo4
Posted - 3 days ago
$CMRX VSTM reported news yesterday that its NDA filed 60 days ago for accelerated approval of its ovarian cancer drug was accepted and that its request for priority review was granted. Its stock price bolted forward. I expect the same thing to happen when CMRX gets its news in early February with regard to its similar NDA. Happy New Year!
zerofighter00
Posted - 12/31/24
$CMRX How long do you CMRX investors expect the results of the review to be available?I have been following CMRX since the monkey pox.
boomshiva
Posted - 12/31/24
$CMRX Out 3.46 for about 10.xx%.
StockAutoPro
Posted - 12/30/24
$CMRX: Add shares at $3.40 targeting $4.50 as biotech activity increases for Chimerix.
Article_AI
Posted - 12/30/24
$CMRX Promising Outlook for Chimerix: Strategic Developments and Financial Strength Justify Buy Rating Soumit Roy, an analyst from JonesTrading, maintained the Buy rating on Chimerix (CMRX – Research Report). The associated price target remains the s... https://www.stck.pro/news/CMRX/97197799/
Article_AI
Posted - 12/30/24
$CMRX Chimerix submits dordaviprone NDA for accelerated approval Chimerix (CMRX) confirms that the Company has submitted a New Drug Application with the U.S. Food and Drug Administration seeking accelerated appro... https://www.stck.pro/news/CMRX/97191979/
pablo4
Posted - 12/30/24
$CMRX is incredibly strong....you have to accept its rhythm. The XBI is having a terrible day.....XBI is the ETF for small biotech, if you didn't know already. The XBI has been going down for days while CMRX has been going up strongly. But the big thing right now, IMO, is the technical issue of being overbought/oversold. CMRX has been so strong since its after-hours news of 3 weeks ago today (it closed regular trading that Monday at .86) that its RSI has not yet come down below 80. It sits on 80 as I'm writing this. It spent a good deal of the time right after the news in the low to mid 90s....which is a very, very overbought situation. If CMRX simmers a little bit, the RSI will continue to settle to a "less overbought" situation. CMRX can then catch its breath and head north again, IMO. If you look at CMRX's stock performance since its news of 3 weeks back and find any weakness here, you need your head examined, IMO.
ARDX_Bull
Posted - 12/30/24
$CMRX The major indexes have gone up so much in 2024 and deservedly so to come down more IMO. But CMRX has been down for the past 2 yrs nonstop until 12/10/24 NDA news broke. we are definitely in up trend until PDUFA day. Meanwhile I am very interested to find out the new fillings since 11/10/24. Huge volumes for small cmrx can’t be just day trades but you be you. SI went up 52-wk high is a great sign. IMO Btw you know why day traders have a 95% rate of losing record even in good stock market ?
Ja094387
Posted - 12/30/24
$CMRX wtf
Funxs
Posted - 12/30/24
$CMRX amazing so few people are following this $1.60 in cash , no need to dilute and a pdufa date coming
ccledez
Posted - 12/30/24
$CMRX I'm happy they submitted their drug But disappointed they didn't pr their compliance.
That could have been $1 gain last week.
Now we will never know. Sigh
ARDX_Bull
Posted - 12/30/24
$CMRX Longs should read the latest presentation after FDA AA NDA news broke on 12/10/24. Keep in mind that the FDA didn't give their permission to file NDA for AA approval without the Company actually started the on-going Ph3 trial !! That tells you the high probability of success rate in passing the same very conservative FDA oncology committee in 6 months!!! Just IMO. https://ir.chimerix.com/static-files/9a8ee054-1b2c-4a31-8ab8-45f38074972b
ARDX_Bull
Posted - 12/30/24
@pablo4 Newcomers, especially those day traders have no idea that the Company did a secondary offer at $8.50 to over subscribed biotech funds 2weeks after the purchase of Oncoceutics for ONC201 back in Jan 8 2021. Afterwards SP shoot up to $11.50 ranges. So why would they do any public offer at the current low SP with over $152 M cash by 9/3024? More importantly at that time, we didnt have FDA approval of Tembexa yet. Nor big load of cash balance but the verbal promise of FDA AA pathway for ONC201 without going through the super high financial costs and 2-3 yrs time consuming PH3. And at 2021 the TAM for ONC201 was at $500 M peak but the latest TAM by Dec 2024 estimates is at >$1Bn in USA alone. Now it‘s getting to the FDA AA decision in 6 months approval timeline. What a great milestone accomplishment! Better time ahead for $cmrx for sure!!!
pablo4
Posted - 12/30/24
$CMRX can we break into the 4s today and outperform the sector ....that is, continue CMRX's strong trend amid the current tepid small bio backdrop? Given today's unexpected news element (the NDA filing was expected) of the amended loan agreement, I think we can blow through 4 this week anyway. JMO.
briefingcom
Posted - 12/30/24
Gapping up: $BOIL +17.3% $PDYN +17% $GRRR +6.7% $CMRX +6.3% $ARTV +5.1%
ARDX_Bull
Posted - 12/30/24
$CMRX Smart indeed! “We also entered into a credit facility of up to $30 million with Silicon Valley Bank providing access to additional capital during this upcoming investment cycle and helping ensure dordaviprone availability to as many patients as possible, as quickly as possible, if approved. We are grateful to our partners at Silicon Valley Bank for their long-term support of Chimerix. This credit facility provides valuable financial optionality leading up to, and through, a potential U.S. launch of dordaviprone,” said Michelle LaSpaluto, Chief Financial Officer of Chimerix.
Grows
Posted - 12/30/24
$WATT, $NXU, $JFBR, and may be $CMRX let see.
Thestocktraderhubzee
Posted - 12/30/24
$CMRX Chimerix Confirms That It Has Submitted New Drug Application With FDA Seeking Accelerated Approval For Dordaviprone As Treatment For Patients With Recurrent H3 K27M-mutant Diffuse Glioma In US
Scanners_Free
Posted - 12/30/24
$CMRX NNNNNNEEEEEEEEWWWWSSSSSS
KingMicroCap
Posted - 12/29/24
$CMRX Congrats bulls! I had this on my WL but missed it
mh191
Posted - 12/28/24
$PGHL o yeah, $CMRX. This will go higher. I am giving you guys trades that will bank for you.
mh191
Posted - 12/28/24
$CMRX
tiger8464
Posted - 12/27/24
$CMRX Buy it !!
